At the end of the Human Genome Project, researcher Niroshan Ramachandran, at the Harvard Institute of Proteomics, opened the door into a much bigger challenge: isolating and measuring the interactions between individual proteins inside DNA. This science, or Proteomics, holds great potential for finding cures to disease and improving healthcare. Ramachandran talks about technologies that are being used to forward this research.

A research associate at the Harvard Institute of Proteomics, Harvard Medical School, Ramachandran has been actively involved in the development of protein microarray technology. This technology, called Nucleic Acid Programmable Protein Array, synthesizes an array of proteins on a solid matrix and overcomes many of the limitations of conventional protein arrays on the market today. He is currently developing this platform technology to be used for biomarker discovery in cancer. His goal is to identify informative antigens that will lead to early diagnosis of diseases and the development of vaccines for immunotherapy.

This podcast is redistributed with permission from Lumera Corporation as part of their series on nanotechnology.

Tags: DNA, Healthcare IT, Human Genome Project, Lumera Corporation, nanotechnology, Niroshan Ramachandran, Proteomics
 
Posted in: Connected Social Media, Enterprise 2.0, Healthcare, RockyMountainVoices